市場調查報告書
商品編碼
1419127
血壓監測設備市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍:按產品、類型、最終用戶和地理位置Blood Pressure Monitoring Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Type, End User, and Geography |
根據我們最新的《2030 年血壓監測設備市場預測 - 全球分析 - 產品、類型和最終用戶》研究,血壓監測設備市場價值預計到 2030 年將從 23.87 億美元增至 53.46 億美元2022 年;預計 2022 年至 2030 年市場CAGR為 10.6%。
該報告強調了推動市場的關鍵因素以及主要參與者的發展。血壓監測設備市場的主要成長動力包括心血管疾病發生率的上升和老年人口的激增。然而,網路安全漏洞的風險阻礙了市場的成長。
在血壓監測設備市場營運的公司專注於策略發展,例如合作、擴張、協議、夥伴關係和新產品發布,這有助於他們提高銷售額,擴大地理覆蓋範圍,並增強迎合更大市場的能力。現有客戶群。以下提到了血壓監測設備市場的一些值得注意的發展:
2023年1月,Valencell在數位健康領域推出了自有品牌產品線。該公司的第一個候選產品專注於幫助患者監測和管理高血壓,使用直覺的應用程式與創新的 OTC 設備相結合,無需袖帶或校準即可透過手指精確測量血壓。
2022 年 10 月,歐姆龍醫療保健公司升級了其血壓監測儀產品組合,將其轉變為「互聯」設備。產品組合的這一重大升級旨在幫助使用者和醫療保健從業者獲得對高血壓管理的無縫、輕鬆、更即時和準確的控制。連接的裝置允許透過 OMRON Connect 應用程式 (app) 輕鬆傳輸血壓資料。
2022 年 2 月,Inbody 推出了新型 BP 170 自動血壓監測儀,為個人提供了在家中自我記錄和追蹤關鍵健康參數的選擇。
2021年6月,Biobeat推出了無袖連續動態血壓監測儀。這款新設備與典型的護理產品不同,因為它沒有袖帶,可以全天捕獲患者心臟健康狀況的資料。
2020 年 12 月,Detel India 的健康與衛生垂直部門 DetelPro 推出了新的數位監控解決方案。這款血壓計配備了語音技術,讓人們可以聽到自己的血壓讀數。它還具有心律不整指示器,通知用戶心跳讀數不規則。該設備由 99 組存儲組成,一次可供 2 人使用,並具有可調節的大臂套,適合各種臂圍。
因此,推出產品和開展新業務以保持市場競爭力將為血壓監測設備市場創造重大成長機會。
根據產品,血壓監測設備市場分為水銀柱血壓計、無液體血壓計和數位血壓計。 2022年,數位血壓細分市場佔據了重要的市場佔有率,預計該細分市場在2022年至2030年期間將實現最快的CAGR。數位血壓測量設備經過卓越的開發,是最好的血壓機器之一,可以提供精確的血壓和脈搏讀數。數位監視器是測量血壓的首選。它們通常比無液裝置更容易使用。數位監視器在一個單元中整合了聽診器和儀表,以及錯誤指示器。血壓讀數顯示在小螢幕上;它可能比錶盤更容易讀取。數位監視器適合聽力受損的患者,因為無需透過聽診器聽心跳。
根據類型,血壓監測設備市場分為手臂式、手腕式、手指式等。 2022年,ARM細分市場佔據最大市場佔有率,預計該細分市場在2022-2030年期間複合CAGR最快。基於手指的血壓監測技術與脈搏血氧測定法類似,因為它利用從使用者手指反射的光,透過光電體積描記圖 (PPG) 來測量血流量,並透過不同的演算法進行解釋。 2023 年 5 月,加州大學聖地牙哥分校的工程師開發了一種簡單、低成本的夾子,它使用智慧型手機的相機和閃光燈來監測使用者指尖的血壓。該剪輯可與客製化智慧型手機應用程式配合使用,目前其製作成本約為 80 美分。研究人員估計,大規模生產時,每個成本可能低至 10 美分。他們聲稱,該設備可以幫助資源匱乏社區的人們輕鬆、負擔得起且易於進行定期血壓監測。它可能有利於老年人和孕婦控制高血壓等疾病。
根據最終用戶,血壓監測設備市場分為醫院和診所、家庭護理機構、門診手術中心等。 2022年,醫院和診所領域佔據了很大的市場。據估計,家庭護理設置領域在 2022 年至 2030 年期間複合CAGR最快。醫院和診所是大多數國家的主要醫療保健提供者。美國心臟協會報告指出,社區居住的中老年成年人心律異常的頻率很高。心房顫動、緩慢性心律不整和傳導系統疾病是節律異常的主要原因。根據記錄,光在美國就有至少 230 萬人受到心律不整的影響,導致中風和死亡的風險增加。
此外,美國每年檢測出 90,000 例室上性心搏過速病例,佔所有因室上性心搏過速而住院的急診就診病例的 25%。除此之外,NCBI 報告指出,在 5,585 例因心律不整入院的患者中,有 2,020 例 (36.1%) 併發心律不整。因此,多專科醫院的數量不斷增加,人們對醫院和診所的偏好超過其他醫療機構。由於上述所有因素,醫院和診所部門可能會在未來幾年內成長。
美國食品藥物管理局 (USFDA)、歐洲心臟病學會和疾病管制與預防中心 (CDC) 是在準備血壓監測設備市場報告時提到的幾個關鍵的主要和次要來源。
註 - 將為以下提到的地區/國家提供類似的分析
注意 - 將為以下公司列表提供類似資訊
According to our latest study on "Blood Pressure Monitoring Devices Market Forecast to 2030 - Global Analysis - Product, Type, and End User," the blood pressure monitoring devices market value is expected to reach US$ 5.346 billion by 2030 from US$ 2.387 billion in 2022; the market is estimated to record a CAGR of 10.6% during 2022-2030.
The report highlights the key factors driving the market and prominent players with their developments. Major growth enablers in the blood pressure monitoring devices market include a rise in the incidence of cardiovascular diseases and an upsurge in the geriatric population. However, the risk of cybersecurity vulnerabilities hampers the market growth.
Companies operating in the blood pressure monitoring devices market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the blood pressure monitoring devices market are mentioned below:
In January 2023, Valencell launched its own branded product line in the Digital Health segment. The company's first product candidate focuses on helping patients monitor and manage hypertension using an intuitive app combined with an innovative OTC device to precisely measure blood pressure from the finger without a cuff or calibration.
In Oct 2022, OMRON Healthcare upgraded its portfolio of blood pressure monitors by converting them into "connected" devices. This major upgrade in the portfolio was meant to help users and healthcare practitioners gain seamless, effortless, more real-time, and accurate control over hypertension management. The connected devices allow the blood pressure data to transfer effortlessly through the OMRON Connect application (app).
In February 2022, Inbody launched its new BP 170 automatic blood pressure monitor, which offers individuals an option to self-record and track key health parameters at home.
In June 2021, Biobeat launched a cuffless continuous ambulatory blood pressure monitor. The new device differs from typical care products as it is cuffless and can capture data on a patient's cardiac health throughout the day.
In December 2020, DetelPro, the health and hygiene vertical of Detel India, launched a new digital monitoring solution. This BP device is equipped with voice technology that allows people to hear their blood pressure readings. It also has an arrhythmia indicator that notifies users of irregular heartbeat readings. This device consists of 99 sets of storage for 2 people at a time and has an adjustable large arm cuff that fits various arm circumferences.
Therefore, introducing products and the initiation of new businesses to remain competitive in the market would create significant growth opportunities in the blood pressure monitoring devices market.
Based on the product, the blood pressure monitoring devices market is segmented into mercury columns, aneroid blood pressure monitors, and digital blood pressure monitors. In 2022, the digital blood pressure segment held a significant market share, and the same segment is estimated to register the fastest CAGR during 2022-2030. Digital blood pressure measuring devices are developed with excellence, and they are among the best blood pressure machines that deliver precise and accurate blood pressure and pulse readings. Digital monitors are preferred for measuring blood pressure. They are often easier to use than aneroid units. Digital monitors have a stethoscope and a gauge in a single unit, along with an error indicator. The blood pressure reading is displayed on a small screen; it may be easier to read than a dial. Digital monitors are suitable for hearing-impaired patients since there is no necessity to listen to heartbeats through stethoscopes.
Based on type, the blood pressure monitoring devices market is segmented into arm, wrist, finger, and others. In 2022, the arm segment held the largest share of the market, and the same segment is estimated to register the fastest CAGR during 2022-2030. The finger-based blood pressure monitoring technology is similar to pulse oximetry, as it uses light that bounces off of the user's finger to measure blood flow using a photoplethysmogram (PPG), which is interpreted with different algorithms. In May 2023, engineers at the University of California San Diego developed a simple, low-cost clip that uses a smartphone's camera and flash to monitor blood pressure at the user's fingertip. The clip works with a custom smartphone app, and its production currently costs ~80 cents. The researchers estimate that the cost could be as low as 10 cents apiece when manufactured at scale. They claim that this device could help make regular blood pressure monitoring easy, affordable, and accessible to people in resource-poor communities. It could benefit older adults and pregnant women in managing conditions such as hypertension.
Based on end users, the blood pressure monitoring devices market is segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held a significant share of the market. The home care settings segment is estimated to register the fastest CAGR during 2022-2030. Hospitals and clinics are the primary healthcare providers in most countries. The American Heart Association, Inc. report states that the frequency of rhythm abnormalities in middle-aged to older community-dwelling adults is substantial. Atrial fibrillation, bradyarrhythmias, and conduction system diseases account for the majority of abnormal rhythm conditions. For records, cardiac arrhythmias affect at least 2.3 million people in the United States alone, resulting in an increased risk of stroke and mortality.
Additionally, 90,000 cases of supraventricular tachycardia are detected annually in the United States, accounting for 25% of all emergency department visits for supraventricular tachycardia resulting in hospitalization. Apart from that, the NCBI report states that out of 5,585 hospital admissions for cardiac arrhythmias, 2,020 (36.1%) had concurrent arrhythmias. Thus, there is a rising number of multi-specialty hospitals and people's preference for hospitals & clinics over other healthcare settings. Owing to all the factors mentioned above, the hospital & clinics segment is likely to grow in the coming years.
United States Food and Drug Administration (USFDA), European Society of Cardiology, and Centers for Disease Control and Prevention (CDC) are a few key primary and secondary sources referred to while preparing the report on the blood pressure monitoring devices market.
Note - Similar analysis would be provided for below mentioned regions/countries
Note - Similar information would be provided for below list of companies